BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6210282)

  • 41. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.
    Rohatagi S; Appajosyula S; Derendorf H; Szefler S; Nave R; Zech K; Banerji D
    J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corticosteroid therapy, nonendocrine disease, and corticosteroid withdrawal.
    Magiakou MA; Chrousos GP
    Curr Ther Endocrinol Metab; 1994; 5():120-4. PubMed ID: 7704695
    [No Abstract]   [Full Text] [Related]  

  • 43. Current controversies in critical illness-related corticosteroid insufficiency and glucocorticoid supplementation.
    Gross AK; Winstead PS
    Orthopedics; 2009 Sep; 32(9):. PubMed ID: 19751024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Limited usefulness of corticosteroid therapy (author's transl)].
    Fujimori I
    Ryumachi; 1981 Mar; 21(1):80-6. PubMed ID: 7025253
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical efficacy and side effects of inhalation corticosteroids in asthma].
    Dekhuijzen PN; Bootsma GP; van Herwaarden CL
    Ned Tijdschr Geneeskd; 1994 Jul; 138(28):1408-13. PubMed ID: 8047180
    [No Abstract]   [Full Text] [Related]  

  • 46. [Corticosteroid therapy in acute viral infections of the nervous system].
    Ackermann R
    MMW Munch Med Wochenschr; 1982 Jan; 124(3):73-4. PubMed ID: 6806628
    [No Abstract]   [Full Text] [Related]  

  • 47. [Current status of knowledge on the changes in the hypothalamo-hypophyseo-adrenal cortex system and their effects in chronic alcohol use and withdrawal].
    Nickel B; Kemper A
    Psychiatr Neurol Med Psychol (Leipz); 1982 Aug; 34(8):449-59. PubMed ID: 6292975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of phospholipids in the bioavailability of an adrenal cortex extract].
    De Rosa G; Corsello SM; Liberale I; Ruffilli MP; Grasso P; Raimondo S; Pasargiklian E
    Clin Ter; 1982 Dec; 103(6):663-70. PubMed ID: 7160148
    [No Abstract]   [Full Text] [Related]  

  • 49. Corticosteroid therapy. I. Pharmacological properties and principles of corticosteroid use.
    Streeten DH
    JAMA; 1975 Jun; 232(9):944-7. PubMed ID: 1173635
    [No Abstract]   [Full Text] [Related]  

  • 50. [Not Available].
    Fath R
    MMW Fortschr Med; 2024 Jun; 166(10):69. PubMed ID: 38806932
    [No Abstract]   [Full Text] [Related]  

  • 51. Corticosteroids in allergy: a 25-year review.
    Grater WC
    Tex Med; 1977 Apr; 73(4):53-9. PubMed ID: 850882
    [No Abstract]   [Full Text] [Related]  

  • 52. Hydrolysis of corticosteroid 17,21-alkylorthoesters in buffered medium. An improved synthesis of 17-monoesters.
    Vitali R; Gardi R
    Farmaco Sci; 1972 Oct; 27(10):818-28. PubMed ID: 5085736
    [No Abstract]   [Full Text] [Related]  

  • 53. The selection of adrenocorticosteroid preparations.
    Kreines K; Weinberg IC
    Ohio State Med J; 1975 Oct; 71(14):698, 703-6. PubMed ID: 52855
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: Dilution of topical corticosteroid formulations.
    Mooney AF; Pearce JD
    Br J Dermatol; 1974 Jan; 90(1):109. PubMed ID: 4811831
    [No Abstract]   [Full Text] [Related]  

  • 55. Peri-operative corticosteroid supplementation for patients on therapeutic glucocorticoids: a national survey.
    Ramesh AV; Pufulete M; Reeves BC; Fletcher S; Tomlinson JW; Gibbison B
    Anaesthesia; 2020 Oct; 75(10):1396-1398. PubMed ID: 32584419
    [No Abstract]   [Full Text] [Related]  

  • 56. [Changes in rat skin proteins during systemic high-dosage corticosteroid medication].
    Rodermund OE
    Acta Endocrinol Suppl (Copenh); 1971; 152():22. PubMed ID: 5313539
    [No Abstract]   [Full Text] [Related]  

  • 57. Pulmonary disease and drug kinetics.
    du Souich P; McLean AJ; Lalka D; Erill S; Gibaldi M
    Clin Pharmacokinet; 1978; 3(4):257-66. PubMed ID: 354634
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Calculation and statistical assessment of kinetic data from infusion experiments.
    Wilson DW; Pierrepoint CG; Griffiths K
    J Endocrinol; 1976 Mar; 68(3):25P-26P. PubMed ID: 1255082
    [No Abstract]   [Full Text] [Related]  

  • 59. ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA.
    GIBALDI M; KANIG JL
    J Oral Ther Pharmacol; 1965 Jan; 1():440-50. PubMed ID: 14232392
    [No Abstract]   [Full Text] [Related]  

  • 60. [Biological and in vitro availability].
    Speiser P
    Pharm Acta Helv; 1971 Aug; 46(8):449-67. PubMed ID: 5092965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.